Patients with poorly differentiated laryngeal cancer, human pancreatic ductal adenocarcinoma (PDAC), and human clear cell renal cell carcinoma (ccRCC) exhibit elevated CD200 expression, suggesting that it may promote immunosuppression as an immune checkpoint [119,120,121]. Here, CD200 is linked to laryngeal carcinoma.